Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Daniela Matarrese, Massimo Edoardo Di Natale, P Lotti, Donatella Aquilini, Giancarlo Landini, Barbara Cimolato, Massimo Antonio Di Pietro, Michele Trezzi, Paolo Stobbione, G Frausini, Assunta Navarra, Emanuele Nicastri, Giovanni Sotgiu, Delia Goletti
Topics & Concepts
MedicinePneumoniaCoronavirus disease 2019 (COVID-19)Intensive care unitSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cytokine stormInternal medicineCoronavirusAdverse effectDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19